




Entertainment
View All
Avon Grove Offers a Quieter, Sensory-Friendly Visit With Santa
WEST GROVE, PA — Meeting Santa Claus can be overwhelming for children with sensory sensitivities, but a special holiday event at Avon Grove High School is creating a quieter, more …
Lifestyle
View All
Malvern Wreath Ceremony Honors 52 Fallen Revolutionary Soldiers
MALVERN, PA — Fifty-two Continental soldiers who lost their lives in the Battle of Paoli will be remembered with Christmas wreaths when the Paoli Battlefield hosts its annual Wreaths Across …
Pennsylvania
View All
Philadelphia Secures Four More Army-Navy Games Through 2034
PHILADELPHIA, PA — Philadelphia will host four additional Army-Navy football games between 2028 and 2034, securing a series of major sporting events expected to generate millions of dollars in tourism …
National
View All
Fetterman Pushes USDA to Halt SNAP Eligibility Restrictions
WASHINGTON, D.C. — U.S. Sen. John Fetterman, D-Pa., joined 10 Senate Democrats in urging the Department of Agriculture to withdraw proposed food assistance restrictions that could eliminate Supplemental Nutrition Assistance …
Latest Articles
View AllParkesburg Man Surrenders on Indecent Exposure Warrant
PARKESBURG, PA — A 30-year-old man surrendered to Parkesburg Borough police Tuesday, Nov. 17, 2026, after authorities obtained an arrest warrant charging him with indecent exposure and related offenses stemming …
Toll Brothers Sets December 7 Release for Quarterly Results
FORT WASHINGTON, PA — Toll Brothers Inc. (NYSE: TOL) will release its fourth-quarter and fiscal 2026 financial results after U.S. stock markets close on December 7, giving investors an updated …
West Whiteland Police Arrest Man on Robbery Warrant
WEST WHITELAND TWP, PA — A 43-year-old man was arrested Wednesday, Nov. 18, 2026, on a warrant involving robbery and related charges, according to the West Whiteland Township Police Department. …
Aro Biotherapeutics Targets Myositis With RNA Therapy
PHILADELPHIA, PA — Aro Biotherapeutics plans to begin clinical testing in 2027 of an experimental RNA-based treatment for inflammatory myositis after laboratory and preclinical studies identified a potential therapeutic target …
Context Therapeutics Reports 22% Response Rate in Cancer Trial
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) reported a 22% confirmed response rate in a small Phase 1 trial of its experimental ovarian cancer treatment, CTIM-76, as the Philadelphia-based …
